Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Spasticity Due to Multiple Sclerosis”

11 trials

Showing 11 of 11 results

Large-scale testing (Phase 3)Study completedNCT00488839
What this trial is testing

IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Impax Laboratories, LLC 173
Large-scale testing (Phase 3)WithdrawnNCT01868048
What this trial is testing

Phase 3, 28-week, Randomized, Double-blind, Placebo-controlled Safety and Efficacy Study of Nabiximols as an add-on Therapy in Subjects With Spasticity Due to Multiple Sclerosis.

Who this might be right for
SpasticityMultiple Sclerosis
GW Research Ltd
Large-scale testing (Phase 3)Study completedNCT03756974
What this trial is testing

BX-1 in Spasticity Due to Multiple Sclerosis

Who this might be right for
Spasticity Due to Multiple Sclerosis
Bionorica SE 397
Large-scale testing (Phase 3)Study completedNCT00702468
What this trial is testing

Evaluate the Maintenance of Effect After Long-term Treatment With Sativex® in Subjects With Symptoms of Spasticity Due to Multiple Sclerosis

Who this might be right for
SpasticityMultiple Sclerosis
Jazz Pharmaceuticals 36
Post-approval studies (Phase 4)Study completedNCT01964547
What this trial is testing

Study of Sativex on Cognitive Function and Mood: Multiple Sclerosis Patients

Who this might be right for
Multiple SclerosisSpasticity
Jazz Pharmaceuticals 121
Large-scale testing (Phase 3)Study completedNCT00681538
What this trial is testing

The Safety and Effectiveness of Sativex®, for the Relief of Symptoms of Spasticity in Subjects, From Phase B, With Multiple Sclerosis (MS)

Who this might be right for
SpasticityMultiple Sclerosis
Jazz Pharmaceuticals 572
Large-scale testing (Phase 3)Study completedNCT03319732
What this trial is testing

Evaluate the Long-term Safety of Arbaclofen Extended-Release Tablets for Patients With Spasticity Due to MS

Who this might be right for
Multiple SclerosisSpasticity, Muscle
RVL Pharmaceuticals, Inc. 323
Large-scale testing (Phase 3)Study completedNCT01359566
What this trial is testing

Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
XenoPort, Inc. 228
Testing effectiveness (Phase 2)WithdrawnNCT01649050
What this trial is testing

Efficacy of 5 Weeks of Treatment With BGG492 in Patients With Spasticity Due to Multiple Sclerosis

Who this might be right for
Muscle Spasticity Due to Multiple Sclerosis
Novartis Pharmaceuticals
Large-scale testing (Phase 3)Ended earlyNCT04203498
What this trial is testing

Safety and Effectiveness of Nabiximols Oromucosal Spray as Add-on Therapy in Participants With Spasticity Due to Multiple Sclerosis

Who this might be right for
Multiple Sclerosis (MS)
Jazz Pharmaceuticals 139
Large-scale testing (Phase 3)Study completedNCT01599234
What this trial is testing

Evaluate the Efficacy of Sativex in Relieving Symptoms of Spasticity Due to Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Jazz Pharmaceuticals 337

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation